Glenmark Pharmaceuticals receives approval for oral contraceptives

21 January 2012: Glenmark Pharmaceuticals has received final approval from the US health regulator for its generic two oral contraceptives tablets. The approval has been granted by the United States Food and Drug Administration (USFDA) to the company's US arm Glenmark Generics Inc, a subsidiary of Glenmark Generics .

The approvals are for the oral contraceptive products Norethindrone and Ethinyl Estradiol (Alyacen TM 1/35) tablets in different strengths. The tablets are generic equivalents of Ortho-McNeil Janssen's 'Ortho-Novum 1/35-28' tablets and 'Ortho-Novum 7/7/7-28' tablets.

Source: Economic Times

.